Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giovanni Cacace is active.

Publication


Featured researches published by Giovanni Cacace.


American Journal of Kidney Diseases | 1993

Angiotensin II Local Hyperreactivity in the Progression of IgA Nephropathy

Rosanna Coppo; Alessandro Amore; Bruno Gianoglio; Giovanni Cacace; Giuseppe Picciotto; Dario Roccatello; L. Peruzzi; Giuseppe Piccoli; P.G. De Filippi

Immunologic and hemodynamic factors are likely to work in synergism in the progression of immunoglobulin A nephropathy (IgAN) toward sclerosis. The local activation of the renin-angiotensin system may be one the most relevant mechanisms. We investigated the hemodynamic effects of the acute administration of angiotensin-converting enzyme inhibitor (ACEI) (captopril 50 mg). The glomerular filtration rate (GFR) and the effective renal plasma flow (ERPF) were measured by 51Cr-EDTA and 125I hippurate clearances. The correspondent filtration fractions (FFs) in basal conditions and after administration of ACEI were calculated, then the changes in FF (delta FF and % delta FF) were determined. We studied 27 IgAN patients. Eighteen patients had normal renal function (GFR, 112 +/- 19 mL/min/1.73 m2) and nine had moderate renal impairment (GFR, 54 +/- 13 mL/min/1.73 m2). Sixteen patients had proteinuria > or = 0.5 g/d. In addition, 12 glomerulonephritis control cases and eight healthy subjects were investigated. After the administration of ACEI in healthy subjects we observed slight modifications in the GFR, a significant increase in the ERPF (P < 0.005), and a significant decrease in FF (P < 0.04). Similarly, in IgAN patients with normal renal function the GFR increased slightly, the ERPF increased significantly (P < 0.01), and there was a decrease in FF (P < 0.01). The delta FF and % delta FF values were not significantly different from those found in the controls. In patients with initial renal failure GFR remained unchanged, ERPF increased significantly (P < 0.005), and FF significantly decreased (P < 0.004). However, the changes in delta FF and % delta FF were significantly greater than those found in healthy controls (P < 0.01) and in IgAN patients with normal renal function (P < 0.001). IgAN patients with proteinuria levels > or = 0.5 g/d showed greater changes in delta FF and % delta FF after the administration of ACEI than patients with proteinuria levels lower than 0.5 g/d (P < 0.003 and P < 0.04, respectively) or proteinuric control cases (P < 0.05 and P < 0.01, respectively). This different response in proteinuric and nonproteinuric patients was evident even when the analysis was limited to the subgroup of IgAN patients with normal renal function. The decrease in FF consequent to an increase in the ERPF after the administration of ACEI suggests a local hyperactivity of the renin-angiotensin system in some cases of IgAN.(ABSTRACT TRUNCATED AT 400 WORDS)


Circulation | 1996

Plasmin Promotes an Endothelium-Dependent Adhesion of Neutrophils Involvement of Platelet Activating Factor and P-Selectin

Giuseppe Montrucchio; Enrico Lupia; A. De Martino; Luigi Silvestro; S. Rizea Savu; Giovanni Cacace; P.G. De Filippi; Giorgio Emanuelli; Giovanni Camussi

BACKGROUND The adhesion of leukocytes to the endothelium and the edema of vessel wall may cause vascular reocclusion after thrombolytic therapy. The aim of this study was to evaluate the role of platelet activating factor (PAF) and P-selectin on the adherence of polymorphonuclear neutrophils (PMN) to the endothelium and of PAF on the increased vascular permeability induced by tissue-type plasminogen activator, streptokinase, and plasmin. METHODS AND RESULTS We studied (1) the adhesion of 111Inlabeled PMN to human umbilical cord vein-derived cultured endothelial cells (HUVEC), (2) the transfer of 125I-labeled albumin across HUVEC monolayers, and (3) the adhesion of PMN to isolated bovine coronary arteries under flow conditions. It was found that the adhesion of PMN, induced by tissue-type plasminogen activator, streptokinase, and plasmin, correlated with the synthesis of PAF by HUVEC and was inhibited by WEB 2170, a PAF receptor antagonist. The adhesion of PMN was also inhibited by the treatment of HUVEC with anti-P-selectin antibodies or of PMN with soluble P-selectin or with anti-CD18 monoclonal antibodies. Plasmin also increased the permeability of HUVEC monolayers, an effect that was partially prevented by WEB 2170. Moreover, plasmin promoted the synthesis of PAF from isolated bovine coronary arteries and the adherence of PMN to the endothelium under flow conditions. The pretreatment of PMN with WEB 2170 or with soluble P-selectin prevented adhesion. CONCLUSIONS The synthesis of PAF by endothelial cells at the site of plasmin generation and the endothelial expression of P-selectin may render the endothelial cell surface proadhesive for neutrophils and may favor a local increase in vascular permeability.


European Journal of Nuclear Medicine and Molecular Imaging | 1992

Estimation of chromium-51 ethylene diamine tetra-acetic acid plasma clearance: a comparative assessment of simplified techniques

Giuseppe Picciotto; Giovanni Cacace; Patrizia Cesana; Roberto Mosso; Roberto Ropolo; P. Giuseppe De Filippi

Chromium-51 ethylene diamine tetra-acetic acid (51Cr-EDTA) total plasma clearance was evaluated using a multi-sample method (i.e. 12 blood samples) as the reference compared with several simplified methods which necessitated only one or few blood samples. The following 5 methods were evaluated: terminal slope-intercept method with 3 blood samples, simplified method of Bröchner-Mortensen and 3 single-sample methods (Constable, Christensen and Groth, Tauxe). Linear regression analysis was performed. Standard error of estimate, bias and imprecision of different methods were evaluated. For 51Cr-EDTA total plasma clearance greater than 30 ml · min−1, the results which most approximated the reference source were obtained by the Christensen and Groth method at a sampling time of 300 min (inaccuracy of 4.9%). For clearances between 10 and 30 ml · min−1, single-sample methods failed to give reliable results. Terminal slope-intercept and Bröchner-Mortensen methods were better, with inaccuracies of 17.7% and 16.9%, respectively. Although sampling times at 180, 240 and 300 min are time-consuming for patients, 51Cr-EDTA total plasma clearance can be accurately calculated for values greater than 10 ml · min−1 using the Bröchner-Mortensen method. In patients with clearance greater than 30 ml · min−1, single-sample techniques provide a good alternative to the multi-sample method; the choice of the method to be used depends on the degree of accuracy required.


American Journal of Kidney Diseases | 1991

The Fate of Aggregated Immunoglobulin A Injected in IgA Nephropathy Patients and Healthy Controls

Dario Roccatello; Giuseppe Picciotto; Rosanna Coppo; Giuseppe Piccoli; Andrea Molino; Giovanni Cacace; Alessandro Amore; Giacomo Quattrocchio; Roberto Ropolo; Roberto Mosso; A. Amoroso; Luigi M. Sena

Organ uptake of IgA-containing immunologically active material was studied in humans by intravenous (IV) injection of 131I-labeled heat-aggregated human secretory IgA (HAS-IgA) in nine patients affected by primary IgA nephropathy and 10 normal volunteers. Aggregated secretory IgA was found to be removed almost exclusively by the liver. The peak activity in liver was reached at 21.1 minutes (range, 18 to 26 minutes) in patients and 19 minutes (range, 14 to 22 minutes) in controls. The rate of increase of liver radioactivity was found to be significantly slower in patients (with a mean slope of 5.0; range, 3.4 to 7.1 v 7.6, 5.6 to 11.4; P less than 0.02). The mean liver to precordium ratio at the peak time was significantly lower in patients (mean value, 2.3; range, 1.9 to 3.1) compared with controls (mean value, 3.3; range, 2.4 to 4.0) (P less than 0.02). These data confirm the pivotal role of the liver in the removal of aggregated IgA in humans and the defective clearance capacity of this test probe in IgA nephropathy patients.


American Journal of Nephrology | 1995

lndium-111-Labeled Granulocyte Head Accumulation in Patients with Wegener’s Granulomatosis

Dario Roccatello; Giuseppe Picciotto; Graziella Gigliola; Giovanni Cacace; Cristiana Rollino; Giacomo Quattrocchio; Loredana Funaro; Pier Giuseppe De Filippi; Giuseppe Piccoli

Among the symptoms of systemic vasculitis, purulent rhinorrhea with painful sinusitis is thought to be relatively specific to Wegener’s granulomatosis (WG). Sixteen patients with rapidly progressive g


Laboratory Investigation | 1993

Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.

Dario Roccatello; Giuseppe Picciotto; Torchio M; Roberto Ropolo; Ferro M; Franceschini R; Giacomo Quattrocchio; Giovanni Cacace; Rosanna Coppo; Luigi M. Sena


Laboratory Investigation | 1992

Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy.

Dario Roccatello; Giuseppe Picciotto; Roberto Ropolo; Rosanna Coppo; Giacomo Quattrocchio; Giovanni Cacace; Andrea Molino; A. Amoroso; Baccega M; Ciro Isidoro


Nephrology Dialysis Transplantation | 2000

Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy

Dario Roccatello; Giulio Mengozzi; Graziella Gigliola; Daniella Rossi; Roberto Mosso; Giovanni Cacace; Renato Polloni; Giulio Cesano; Giuseppe Picciotto; Luciana Paradisi; Enrico Bancale; Giuseppe Piccoli; Luigi M. Sena


Clinical Immunology and Immunopathology | 1997

Processing of IgA Aggregates in a Rat Model of Chronic Liver Disease

Alessandro Amore; Dario Roccatello; Giuseppe Picciotto; Steven N. Emancipator; Roberto Ropolo; Giovanni Cacace; Adolfo Suriani; Bruno Gianoglio; Luigi M. Sena; Paola Cirina; Gianna Mazzucco; Victor Alfieri; Giuseppe Piccoli; Rosanna Coppo; Pier Giuseppe De Filippi


Nephrology Dialysis Transplantation | 2004

Renal functional assessment in the failing renal graft: what to do where clearances show discrepancy

Giorgina Barbara Piccoli; Antonella Sargiotto; Massimo Gai; Giovanni Cacace; Elisabetta Mezza; Maura Rossetti; Francesca Bermond; Giorgio Soragna; Alberto Jeantet; Giacomo Lanfranco; Giuseppe Picciotto; Giuseppe Paolo Segoloni

Collaboration


Dive into the Giovanni Cacace's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rosanna Coppo

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alessandro Amore

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge